NkMax Co., Ltd. (182400)
KRX SM KRX SM Primary Summary
NkMax Co., Ltd. (182400) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has NkMax Co., Ltd. ever had a stock split?
NkMax Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Sangwoo Park CEO | KRX SM Exchange | KR7182400002 ISIN |
| South Korea Country | 134 Employees | - Last Dividend | 27 Dec 2017 Last Split | - IPO Date |
Overview
NKMAX CO., Ltd. is a South Korean biotechnology firm that specializes in the development, manufacture, and sale of biological products. Founded in 2002 and headquartered in Seongnam-si, South Korea, NKMAX has emerged as a leader in immunotherapy treatments, particularly for cancer. The company initially operated under the name ATGen Co before rebranding to NKMAX CO., Ltd. in 2019. Its focus is on leveraging the power of the immune system to combat cancer, enhancing the body’s natural killer (NK) cells' ability to destroy cancer cells. NKMAX’s innovative approach to cancer treatment and immune system support has positioned it at the forefront of the biotechnology sector in South Korea.
Products and Services
- Anti-cancer Immunotherapy Treatment
- Natural Killer Cell Activity Test for Cancer Patients
- NK VUE Kit
- NK365
- Recombinant Proteins and Monoclonal Antibodies
- NK PUPPY
This cutting-edge treatment is designed to activate the immune cells within the body to target and kill cancer cells. Utilizing the body's own defense mechanisms, this therapy offers a promising avenue for cancer treatment.
A diagnostic service that evaluates the activity of natural killer cells in cancer patients. By analyzing the body's natural defense against cancer, this test helps in understanding the patient's immune response to cancer.
The NK VUE Kit is an innovative test kit that measures the activity of NK cells by quantitatively assessing the level of IFN-gamma released from activated NK cells with just a small amount of blood. This allows for an efficient and effective evaluation of the immune system's capacity to combat cancer.
A proprietary blend of vitamins, minerals, and Agaricus mushroom extract, NK365 is designed to support and enhance the immune system. This dietary supplement provides nutritional support aimed at maintaining optimal immune function.
NKMAX CO., Ltd. also specializes in the production of recombinant proteins and monoclonal antibodies, which are critical components in the development of various therapeutic and diagnostic applications in the realm of biomedicine.
Extending its innovative approach to animal health, NKMAX has developed NK PUPPY, a test that measures a dog's immunity. This test provides pet owners and veterinarians with crucial information on the immune status of dogs, aiding in the management of their health and well-being.
